undamentalytics Newsletter
Sign in

Myomo, Inc. cash flow statement

In fiscal 2025, Myomo, Inc.'s operations generated −$14.5m of cash; it spent $1.7m on capital projects, leaving free cash flow of −$16.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−3−6−10−10−9−10−10−6−3−15−7
Depreciation and amortisation00000000011
Stock-based pay00111111123
Capital spending00000000121
Free cash flow−3−6−10−10−9−10−10−6−5−16−8
Free cash flow after stock pay−3−6−11−11−10−11−12−7−6−18−11
Shares issued—10———1—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: MYO vs SNWVMYO vs TLSIKRMD vs MYO

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Myomo, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Myomo, Inc.